FOLLOW-UP VESSEL WALL MR IMAGING TO EXPLORE SEX-DIFFERENCES OF INTRACRANIAL ARTERIAL WALL CHANGES AND INTRACRANIAL ATHEROSCLEROTIC PLAQUE TREATMENT EFFICACY

  • STATUS
    Recruiting
Updated on 19 February 2024

Summary

Mortality related to cardiovascular disease in the US is improving. Yet the rate of decline is less for women than for men. Women's health is unique due to the varying reproductive stages, and differences are further heightened by sex-specific molecular and cellular characteristics of the heart and vasculature. These biophysiological distinctions may help explain sex disparities in risk factor burden and outcomes after a stroke. While women have some unique risk factors, the predominant risk factors for stroke, such as hypertension and hyperlipidemia, are similar between the sexes. However, the frequency of each risk factor varies resulting in differing population attributable risks. Effective screening and early management of these modifiable risk factors will have the greatest impact to stroke prevention. The same risk factors for cardiovascular disease also underlie the development of intracranial atherosclerotic disease (ICAD), a leading cause of stroke. Yet surprisingly, the development and progression of ICAD has not been explored in women despite the intimate association with stroke. High-resolution vessel wall MR imaging (VWI) permits visualization of vessel wall changes and may potentially serve as a noninvasive screening test for populations of women for early ICAD detection. We propose a study to prospectively evaluate women and men with stroke using VWI to estimate the prevalence of vessel wall abnormalities leading to stroke. Early detection of vessel wall changes in correlation with modifiable risk factors will help us identify opportunities for early prevention of stroke in women. Additionally, longitudinal imaging data and statin non-adherence questionnaires will provide data to evaluate the efficiency of stroke treatment post intervention and identify reasons for non-adherence.

Details
Condition neurology
Age 99years or below
Clinical Study IdentifierTBD
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.